Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Opravil

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 16, 2005
Long-term survival and interruption of HAART in HIV-related pulmonary hypertensionA S Zinkernagel, J von Overbeck, M Opravil, et al.
Antiviral Therapy|February 22, 2000
Improvement in immune function due to treatment with indinavir despite severe immune deficiencyM Rothen, L R Bisset, H I Joller-Jemelka, et al.
The Annals of Thoracic Surgery|June 1, 1986
Use of a counterpulsation balloon as a substitute for the pulmonic valve: a new applicationJ Frederiksen, M N Ilbawi, A J Gorman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cellsG A Funk, M Fischer, B Joos, et al.
Deutsche Medizinische Wochenschrift (1946)|July 3, 1992
[Diagnosis and course of patients with HIV infections and exclusion of Pneumocystis carinii pneumonia]A U Teuscher, M Opravil, R Speich, et al.
The Annals of Thoracic Surgery|September 1, 1984
Pulmonary artery balloon counterpulsation for right ventricular failure: II. Clinical experienceJ M Moran, M Opravil, A J Gorman, et al.
AIDS Research and Human Retroviruses|December 22, 1999
Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohortD Paris, B Ledergerber, R Weber, et al.
Journal of Clinical Microbiology|April 16, 1999
Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissuesM Fischer, W Huber, A Kallivroussis, et al.
AIDS (London, England)|May 1, 1997
Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasmaJ Böni, M Opravil, Z Tomasik, et al.
Infection|March 1, 1994
Phase I/II vaccination study of recombinant peptide F46 corresponding to the HIV-1 transmembrane protein coupled with 2.4 dinitrophenyl (DNP) FicollS Schwander, M Opravil, R Lüthy, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 16, 2005
Long-term survival and interruption of HAART in HIV-related pulmonary hypertensionA S Zinkernagel, J von Overbeck, M Opravil, et al.
Antiviral Therapy|February 22, 2000
Improvement in immune function due to treatment with indinavir despite severe immune deficiencyM Rothen, L R Bisset, H I Joller-Jemelka, et al.
The Annals of Thoracic Surgery|June 1, 1986
Use of a counterpulsation balloon as a substitute for the pulmonic valve: a new applicationJ Frederiksen, M N Ilbawi, A J Gorman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cellsG A Funk, M Fischer, B Joos, et al.
Deutsche Medizinische Wochenschrift (1946)|July 3, 1992
[Diagnosis and course of patients with HIV infections and exclusion of Pneumocystis carinii pneumonia]A U Teuscher, M Opravil, R Speich, et al.
The Annals of Thoracic Surgery|September 1, 1984
Pulmonary artery balloon counterpulsation for right ventricular failure: II. Clinical experienceJ M Moran, M Opravil, A J Gorman, et al.
AIDS Research and Human Retroviruses|December 22, 1999
Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohortD Paris, B Ledergerber, R Weber, et al.
Journal of Clinical Microbiology|April 16, 1999
Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissuesM Fischer, W Huber, A Kallivroussis, et al.
AIDS (London, England)|May 1, 1997
Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasmaJ Böni, M Opravil, Z Tomasik, et al.
Infection|March 1, 1994
Phase I/II vaccination study of recombinant peptide F46 corresponding to the HIV-1 transmembrane protein coupled with 2.4 dinitrophenyl (DNP) FicollS Schwander, M Opravil, R Lüthy, et al.
Pageof 12